Pfizer begins safety tests on new eczema drug in healthy volunteers
NCT ID NCT06686797
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 30 times
Summary
This early-stage study tests the safety of a new medicine called PF-08049820, being developed for eczema (atopic dermatitis). About 71 healthy adults will receive either the drug or a placebo to see how the body processes it and if food affects absorption. The goal is to gather safety data before testing in people with eczema.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.